KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 21, 2025 >>  ABB India 5242.45  [ 0.26% ]  ACC 1845  [ 0.74% ]  Ambuja Cements 567.75  [ 0.39% ]  Asian Paints Ltd. 2508.35  [ -0.22% ]  Axis Bank Ltd. 1235.9  [ 0.80% ]  Bajaj Auto 9109.7  [ -0.27% ]  Bank of Baroda 270.1  [ -0.48% ]  Bharti Airtel 2043.35  [ -0.39% ]  Bharat Heavy Ele 234.6  [ 0.34% ]  Bharat Petroleum 339.1  [ 0.43% ]  Britannia Ind. 6061  [ -0.14% ]  Cipla 1663.85  [ 1.50% ]  Coal India 391.05  [ 0.12% ]  Colgate Palm. 2259.4  [ 0.70% ]  Dabur India 506.2  [ 0.33% ]  DLF Ltd. 771.7  [ -0.26% ]  Dr. Reddy's Labs 1289.55  [ 0.56% ]  GAIL (India) 178.3  [ -0.06% ]  Grasim Inds. 2869  [ 0.47% ]  HCL Technologies 1487.85  [ -0.53% ]  HDFC Bank 1007.3  [ 0.40% ]  Hero MotoCorp 5630  [ -0.16% ]  Hindustan Unilever L 2592.3  [ -0.03% ]  Hindalco Indus. 785  [ -0.22% ]  ICICI Bank 1382.2  [ -0.63% ]  Indian Hotels Co 744.2  [ 0.12% ]  IndusInd Bank 758.35  [ -0.17% ]  Infosys L 1472  [ 0.72% ]  ITC Ltd. 412.85  [ -0.02% ]  Jindal Steel 1006.9  [ 0.13% ]  Kotak Mahindra Bank 2196  [ -0.82% ]  L&T 3887.1  [ 0.35% ]  Lupin Ltd. 1941.5  [ -0.17% ]  Mahi. & Mahi 3619.65  [ 0.60% ]  Maruti Suzuki India 16389.5  [ -0.26% ]  MTNL 41.84  [ 0.75% ]  Nestle India 1286.75  [ 0.14% ]  NIIT Ltd. 105.9  [ 1.53% ]  NMDC Ltd. 75.62  [ 0.48% ]  NTPC 342.1  [ 0.00% ]  ONGC 248.05  [ -0.22% ]  Punj. NationlBak 117.7  [ -0.34% ]  Power Grid Corpo 288.75  [ 0.36% ]  Reliance Inds. 1465.15  [ -0.11% ]  SBI 908.1  [ 0.14% ]  Vedanta 475.6  [ 0.35% ]  Shipping Corpn. 231.5  [ 2.39% ]  Sun Pharma. 1690.3  [ 0.10% ]  Tata Chemicals 912.6  [ 1.05% ]  Tata Consumer Produc 1174.6  [ -0.20% ]  Tata Motors Passenge 401.9  [ 0.55% ]  Tata Steel 172.8  [ 0.52% ]  Tata Power Co. 398.45  [ -0.30% ]  Tata Consultancy 3007.25  [ -0.23% ]  Tech Mahindra 1446.5  [ 0.12% ]  UltraTech Cement 12346.5  [ 0.08% ]  United Spirits 1359.55  [ -0.44% ]  Wipro 241.45  [ 0.08% ]  Zee Entertainment En 104.4  [ 0.24% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

DR. LALCHANDANI LABS LTD.

21 October 2025 | 12:00

Industry >> Hospitals & Medical Services

Select Another Company

ISIN No INE871Z01013 BSE Code / NSE Code 541299 / DLCL Book Value (Rs.) 22.98 Face Value 10.00
Bookclosure 30/09/2024 52Week High 29 EPS 0.96 P/E 24.51
Market Cap. 10.22 Cr. 52Week Low 10 P/BV / Div Yield (%) 1.03 / 0.00 Market Lot 4,000.00
Security Type Other

NOTES TO ACCOUNTS

You can view the entire text of Notes to accounts of the company for the latest year
Year End :2024-03 

2.11 Provisions, contingent liability and contingent asset

Provisions are recognised when the Company has a present obligation (legal or constructive)
as a result of a past event, it is probable that the Company will be required to settle the
obligation, and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle
the present obligation at the end of the reporting period, taking into account the risks and
uncertainties surrounding the obligation. When a provision is measured using the cash flows
estimated to settle the present obligation, its carrying amount is the present value of those cash
flows (when the effect of the time value of money is material).

Contingent assets are disclosed in the financial statements by way of notes to accounts when an
inflow of economic benefits is probable.

Contingent liabilities are disclosed in the financial statements by way of notes to accounts,
unless possibility of an outflow of resources embodying economic benefit is remote.

2.12 Financial instruments

Financial assets and financial liabilities are recognised when Company becomes a party to the
contractual provisions ofthe instruments.

Financial assets and financial liabilities are initially measured at fair value. Transaction costs
that are directly attributable to the acquisition or issue of financial assets and financial liabilities
(other than financial assets and financial liabilities at fair value through profit or loss) are added
to or deducted from the fair value of the financial assets or financial liabilities, as appropriate,
on initial recognition. Transaction costs directly attributable to the acquisition of financial assets
or financial liabilities at fair value through profit or loss are recognised immediately in the
Statement of Profit and Loss.

2.12.1. Cash and cash equivalents

The Company considers all highly liquid financial instruments, which are readily
convertible into known amounts of cash that are subject to an insignificant risk of change
in value and having original maturities of three months or less from the date of purchase,
to be cash equivalents. Cash and cash equivalents consist of balances with banks which
are unrestricted for withdrawal and usage.

2.13 Earnings per share

Basic earnings per share are computed by dividing the profit after tax by the weighted average
number of equity shares outstanding during the year. Diluted earnings per share is computed
by dividing the profit after tax as adjusted for dividend, interest and other charges to expense
or income (net of any attributable taxes) relating to the dilutive potential equity shares by the
weighted average number of equity shares considered for deriving basic earnings per share and

also the weighted average number of equity shares that could have been issued upon
conversion of all dilutive potential equity shares.

2.14 Operating cycle

The Company has determined its operating cycle as 12 months for the purpose of classification
of its assets and liabilities as current and non-current.

2.15 Cash Flow Statement

Cash flows are reported using the indirect method, whereby profit for the year is adjusted for
the effects of transactions of a non-cash nature, any deferrals or accruals of past or future
operating cash receipts or payments and item of income or expenses associated with investing
or financing cash flows. The cash flows are segregated into operating, investing and financing
activities.

2.16 Dividends

The company has not declared any dividend for the financial year 2023-2024.

2.17 Use of estimates and judgements

The preparation of financial statements in conformity with AS requires management to make
judgements, estimates and assumptions that a ffect the application of accounting policies and
the reported amount of assets, liabilities, income, expenses and disclosures of contingent assets
and liabilities at the date of these financial statements and the reported amount of revenues and
expenses for the years presented. Actual results may differ from the estimates.

Estimates and underlying assumptions are reviewed at each balance sheet date. Revisions to
accounting estimates are recognised in the period in which the estimates are revised and future
periods affected.

2.18 Loans availed

During the year under consideration, the company has not availed any new term loan on the
security of current assets and immovable property of the company. The company has only
availed few business loans for day to day business operations secured by way of personal
guarantees of the promoter directors.

2.19 Related Party Disclosures

I. Names of related parties and related party relationship
Dr. Arjan Lalchandani (Managing Director of the Company)

Mr. Mohit Lalchandani (Whole-time Director and CEO of the Company)

Mrs. Anchal Gupta (Executive Director/ CFO of the Company)

a. Entities in which key managerial personnel can exercise significant influence
1 CPC Blood Bank

b. Key Managerial Personnel

1 Dr Arjan Lalchandani - Chairman and Managing Director

2 Mr. Mohit Lalchandani - Whole time Director / CEO

3 Mrs. Anchal Gupta- Executive Director / CFO

c. Relatives of Key Managerial Personnel

Ms. Manica Gupta - Non Executive Director (Sister of Anchal Gupta)

For Jain Agarwal & Company For and on behalf of DR LALCHANDANI LABS LIMITED

Chartered Accountants
FRN: 024866N

Sd/- Sd/-

CA Karan Jain Arjan Lalchandani

Partner Chairman & Managing Director

Membership No. 521992 DIN: 07014579

Place: New Delhi
Date: 30th May, 2024